IL165910A0 - Compositions of hyaluronic acid and methods of use - Google Patents
Compositions of hyaluronic acid and methods of useInfo
- Publication number
- IL165910A0 IL165910A0 IL16591003A IL16591003A IL165910A0 IL 165910 A0 IL165910 A0 IL 165910A0 IL 16591003 A IL16591003 A IL 16591003A IL 16591003 A IL16591003 A IL 16591003A IL 165910 A0 IL165910 A0 IL 165910A0
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- methods
- hyaluronic acid
- hyaluronic
- acid
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
- 229920002674 hyaluronan Polymers 0.000 title 1
- 229960003160 hyaluronic acid Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
- A61K49/0043—Fluorescein, used in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Eyeglasses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39395402P | 2002-07-03 | 2002-07-03 | |
| PCT/US2003/021034 WO2004004744A1 (fr) | 2002-07-03 | 2003-07-03 | Compositions d'acide hyaluronique et procedes d'utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL165910A0 true IL165910A0 (en) | 2006-01-15 |
Family
ID=30115663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16591003A IL165910A0 (en) | 2002-07-03 | 2003-07-03 | Compositions of hyaluronic acid and methods of use |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060094643A1 (fr) |
| EP (1) | EP1539193A4 (fr) |
| JP (2) | JP4818608B2 (fr) |
| CN (3) | CN103638040A (fr) |
| AU (1) | AU2003256381A1 (fr) |
| BR (1) | BRPI0312331A2 (fr) |
| CA (1) | CA2491054A1 (fr) |
| IL (1) | IL165910A0 (fr) |
| MX (1) | MXPA05000186A (fr) |
| NZ (1) | NZ537735A (fr) |
| RU (1) | RU2005102604A (fr) |
| WO (1) | WO2004004744A1 (fr) |
Families Citing this family (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7722808B2 (en) | 2003-09-12 | 2010-05-25 | Novartis Ag | Method and kits for sterilizing and storing soft contact lenses |
| JP2005200386A (ja) * | 2004-01-19 | 2005-07-28 | Chisso Corp | リパーゼ阻害効果、脂肪吸収抑制効果及びコレステロール吸収抑制効果を有する薬剤 |
| US20060083732A1 (en) * | 2004-06-30 | 2006-04-20 | Arlene Gwon | Hyaluronic acid in the enhancement of lens regeneration |
| US20080075756A1 (en) * | 2004-06-30 | 2008-03-27 | Advanced Medical Optics, Inc. | Enhancement of lens regeneration using materials comprising polymers |
| US8802651B2 (en) * | 2004-06-30 | 2014-08-12 | Abbott Medical Optics Inc. | Hyaluronic acid in the enhancement of lens regeneration |
| FR2873379B1 (fr) * | 2004-07-23 | 2008-05-16 | Jerome Asius | Procede de preparation d'acide hyaluronique reticule, acide hyaluronique reticule susceptible d'etre obtenu par ledit procede, implant contenant ledit acide hyaluronique reticule, et son utilisation |
| JP4845359B2 (ja) * | 2004-09-16 | 2011-12-28 | 弘 竹田 | 口腔ケア用組成物 |
| DE602006006424D1 (de) * | 2005-02-09 | 2009-06-04 | Safilens S R L | Ackung zur aufbewahrung und pflege einer kontaktlinse |
| ITMI20052036A1 (it) * | 2005-10-26 | 2007-04-27 | Professional Dietetics Srl | Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato |
| CN101432311A (zh) * | 2006-02-28 | 2009-05-13 | 诺维信生物聚合物公司 | 透明质酸衍生物 |
| EP2010100B1 (fr) * | 2006-04-27 | 2018-11-28 | Johnson & Johnson Surgical Vision, Inc. | Matériaux comprenant des polymères de polysiloxane pour une amélioration de la régénération du cristallin |
| ITPD20060219A1 (it) * | 2006-05-31 | 2007-12-01 | Fidia Farmaceutici | Composizioni farmaceutiche contenenti acido ialuronico solfatato nel trattamento dell'osteoartrosi |
| JP2007320906A (ja) * | 2006-06-01 | 2007-12-13 | Shiseido Co Ltd | 小じわ改善剤 |
| JP2008063334A (ja) * | 2006-08-10 | 2008-03-21 | Lion Corp | 水溶性有効成分の付着化組成物及び水溶性有効成分の付着方法 |
| US8609634B2 (en) | 2007-05-16 | 2013-12-17 | Mcneil-Ppc, Inc. | Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods |
| US9579341B2 (en) | 2007-05-16 | 2017-02-28 | Johnson & Johnson Consumer Inc. | Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods |
| US10092524B2 (en) | 2008-06-11 | 2018-10-09 | Edge Therapeutics, Inc. | Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage |
| US20090036404A1 (en) * | 2007-08-02 | 2009-02-05 | Macleod Steven K | Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof |
| US8689971B2 (en) | 2007-08-31 | 2014-04-08 | Novartis Ag | Contact lens packaging solutions |
| TWI419719B (zh) | 2007-08-31 | 2013-12-21 | Novartis Ag | 隱形眼鏡產物 |
| US20090068122A1 (en) * | 2007-09-06 | 2009-03-12 | Shira Pilch | Dentifrice Compositions for Treating Xerostomia |
| AU2009212321B2 (en) | 2008-02-08 | 2012-04-19 | Colgate-Palmolive Company | Compositions and methods for the treatment of xerostomia |
| US20100075420A1 (en) * | 2008-03-14 | 2010-03-25 | Anita Saraf | Novel Gene Delivery Vectors for Human Mesenchymal Stem Cells |
| AU2009228217A1 (en) | 2008-03-28 | 2009-10-01 | The Regents Of The University Of California | Polypeptide-polymer conjugates and methods of use thereof |
| CN102177180A (zh) | 2008-04-04 | 2011-09-07 | 犹他州大学研究基金会 | 烷基化半合成的糖胺聚糖醚及其制备和使用方法 |
| US20100022471A1 (en) * | 2008-07-23 | 2010-01-28 | Sage Products Inc. | Oral Moisturizer for Alleviating Dry Mouth |
| EP3246048B1 (fr) | 2009-02-18 | 2024-04-03 | Calm Water Therapeutics LLC | Utilisation d'un copolymère bifonctionnel pour des applications ophtalmiques |
| WO2010099543A2 (fr) * | 2009-02-27 | 2010-09-02 | Inter-Med, Inc. | Compositions et procédés pour la détection d'un néoplasme oral |
| IT1397246B1 (it) | 2009-05-14 | 2013-01-04 | Fidia Farmaceutici | Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica |
| JP5601805B2 (ja) * | 2009-08-24 | 2014-10-08 | キユーピー株式会社 | 経口用ドライアイ改善剤、ならびに前記経口用ドライアイ改善剤を含む食品組成物および医薬品組成物 |
| KR20130057969A (ko) * | 2010-02-22 | 2013-06-03 | 에쥐 세라피틱스, 인코포레이티드 | 뇌의 출혈성 병상을 치료하기 위한 방법 및 조성물 |
| US20110212196A1 (en) * | 2010-03-01 | 2011-09-01 | Maine Conservation Medicine Center | Therapeutic oil composition containing carvone |
| ITUD20100112A1 (it) * | 2010-06-09 | 2011-12-10 | Farma Derma S R L | Preparazione per uso vaginale e rettale e relativo procedimento di produzione |
| JP6062917B2 (ja) | 2011-03-23 | 2017-01-18 | ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション | 泌尿器科の炎症の治療及び予防の方法 |
| SG10201602665UA (en) | 2011-04-05 | 2016-05-30 | Edge Therapeutics | Intraventricular Drug Delivery System For Improving Outcome After A Brain Injury Affecting Cerebral Blood Flow |
| US20130108550A1 (en) * | 2011-10-26 | 2013-05-02 | Abbott Cardiovasculr Systems, Inc. | Bioabsorbable Co-Filler for Cerebrovascular Aneurysms |
| JP5840107B2 (ja) * | 2012-06-17 | 2016-01-06 | コスメディ製薬株式会社 | ヒアルロン酸ゲル及びその製造方法 |
| KR101498510B1 (ko) * | 2012-06-26 | 2015-03-04 | 서울대학교산학협력단 | 히알루론산을 포함하는 인공 타액 조성물 |
| US10011832B2 (en) * | 2012-09-05 | 2018-07-03 | Sylentis Sau | SiRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions |
| US20140178327A1 (en) * | 2012-12-21 | 2014-06-26 | Coopervision International Holding Company, Lp | Antimicrobial Ophthalmic Devices |
| PL3613423T3 (pl) | 2013-07-10 | 2023-02-13 | Matrix Biology Institute | Kompozycje hialuronanu o dużej sprężystości i ich zastosowanie |
| WO2015036576A1 (fr) * | 2013-09-12 | 2015-03-19 | Dsm Ip Assets B.V. | Dispositif oculaire |
| RU2551312C1 (ru) * | 2014-04-24 | 2015-05-20 | Людмила Владимировна Уварова | Способ восстановления тканей зубочелюстной системы |
| US10695290B2 (en) * | 2014-05-19 | 2020-06-30 | A. Ebbie Soroudi, M.D., M.S., A Professional Medical Corporation | Non-irritating, non-blurring, photostable ophthalmic sunscreen composition |
| EP3154550B1 (fr) | 2014-06-15 | 2021-08-04 | Yeda Research and Development Co. Ltd. | Traitement de surface par des polymères hydrosolubles et des lipides/liposomes |
| JP6457281B2 (ja) * | 2015-01-29 | 2019-01-23 | 学校法人東京電機大学 | 修飾ヒアルロン酸及び／又はその塩、並びにその製造方法 |
| US20160279108A1 (en) * | 2015-02-24 | 2016-09-29 | University Of Kansas | Targeted mtor inhibitors |
| US20180185276A1 (en) * | 2015-03-26 | 2018-07-05 | Mitotech S.A. | Contact lenses carrying mitochonrially-targeted antioxidants |
| EP3108874A1 (fr) * | 2015-06-26 | 2016-12-28 | TRB Chemedica AG | Préparation pharmaceutique pour application à l'oeil |
| RU2020123728A (ru) * | 2015-09-24 | 2021-01-18 | Матрикс Байолэджи Инститьют | Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения |
| DK3383631T3 (da) | 2015-12-03 | 2019-10-28 | Novartis Ag | Emballeringsopløsninger til kontaktlinser |
| CA3022905A1 (fr) | 2015-12-09 | 2017-06-15 | The Regents Of The University Of California | Methodes de traitement d'une maladie ou d'un trouble oculaire |
| DE102016204472A1 (de) * | 2016-03-17 | 2017-09-21 | Ursapharm Arzneimittel Gmbh | Kit zur kosmetischen Behandlung des Auges und der Haut und Kosmetikum zur Anwendung am Auge und auf der Haut |
| CA3049286C (fr) * | 2016-04-25 | 2022-08-30 | Mizhou Hui | Application de fragments d'acide hyaluronique a faible masse moleculaire |
| EP3241895A1 (fr) * | 2016-05-04 | 2017-11-08 | ETH Zürich, ETH Transfer | Hydrogels d'hyaluronane de poids moleculaire eleve induits par transglutaminase |
| AU2016413933B2 (en) | 2016-07-06 | 2023-06-15 | Calm Water Therapeutics Llc | Bi-functional co-polymer use for ophthalmic and other topical and local applications |
| IT201600079633A1 (it) * | 2016-07-28 | 2018-01-28 | Fidia Farm Spa | Procedimento di preparazione e purificazione del sale sodico dell’acido ialuronico |
| WO2018053111A1 (fr) | 2016-09-15 | 2018-03-22 | University Of Utah Research Foundation | Compositions de gélification in situ pour le traitement ou la prévention d'une inflammation et d'une lésion tissulaire |
| KR20190068575A (ko) * | 2016-10-14 | 2019-06-18 | 이콤 메디칼 게엠베하 | 안구 표면 항상성의 확립, 회복 및 보존 방법 |
| JP6338715B2 (ja) * | 2017-02-06 | 2018-06-06 | ナンヤン テクノロジカル ユニヴァーシティー | 眼用及び医療用の重合性組成物及びそれを重合して得られる抗菌性組成物 |
| JP6868314B2 (ja) * | 2017-07-26 | 2021-05-12 | ユーレー カンパニー リミテッドＹｏｕｒｅｈ Ｃｏ．，Ｌｔｄ． | ヒアルロン酸−カルシウム及びポリリシンを含む創傷被覆材及びその製造方法 |
| US11129862B2 (en) | 2017-08-30 | 2021-09-28 | Johnson & Johnson Consumer Inc. | Ophthalmic compositions |
| WO2020057606A1 (fr) * | 2018-09-20 | 2020-03-26 | The Hong Kong University Of Science And Technology | Compositions de gouttes oculaires |
| CN118512390A (zh) * | 2018-09-20 | 2024-08-20 | 香港科技大学 | 滴眼剂组合物 |
| CN111228653A (zh) | 2018-11-13 | 2020-06-05 | 格莱科米拉治疗公司 | 用电离辐射加强癌症治疗的方法 |
| JP2022514257A (ja) * | 2018-12-13 | 2022-02-10 | アイノス，インコーポレイテッド | ドライアイ疾患の治療のための局所点眼製剤におけるｌｘｒアゴニスト |
| US20220354633A1 (en) * | 2019-05-07 | 2022-11-10 | Cornell University | Temporary synthetic carrier for corneal tissue insertion and tissue delivery |
| CN112494710B (zh) * | 2019-09-16 | 2021-12-14 | 天津大学 | 一种转谷氨酰胺酶促交联的双网络粘合剂及其制备方法 |
| RU2716023C1 (ru) * | 2019-09-20 | 2020-03-05 | Акционерное Общество "Свобода" (Ао "Свобода") | Активный комплекс для приготовления композиций по уходу за полостью рта |
| MX2022010104A (es) | 2020-02-18 | 2022-09-05 | Sunstar Americas Inc | Composicion para el cuidado bucal. |
| KR102479119B1 (ko) * | 2020-10-07 | 2022-12-19 | 주식회사 휴메디솔 | 생체적합성 mpc 고분자 기반의 콘택트렌즈 다기능 용액 및 이의 제조방법 |
| CN115317505A (zh) * | 2021-05-10 | 2022-11-11 | 傅毓秀 | 玻尿酸用于制备治疗肺纤维化药剂的用途 |
| EP4180032A1 (fr) * | 2021-11-16 | 2023-05-17 | National University of Ireland Galway | Traitement par modulation des tissus excitables et des nerfs |
| TWI815436B (zh) * | 2022-05-10 | 2023-09-11 | 長庚大學 | 使用聚離胺酸奈米粒子來治療乾眼症 |
| CN118286154A (zh) * | 2024-03-19 | 2024-07-05 | 山东焦点福瑞达生物股份有限公司 | 一种针对男性私处的植物透明质酸护理液及其制备方法 |
Family Cites Families (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US559104A (en) * | 1896-04-28 | Street-railroad-car advertising device | ||
| US2583096A (en) * | 1949-01-15 | 1952-01-22 | Searle & Co | Process for the production of high viscosity hyaluronic acid |
| US3792164A (en) * | 1970-03-31 | 1974-02-12 | Chemway Corp | Ophthalmic composition comprising water-soluble alkaloid salts of polyuronic acids |
| US3870791A (en) * | 1972-04-24 | 1975-03-11 | Heskel M Haddad | Solid state ophthalmic medication delivery method |
| JPS5318520B2 (fr) * | 1972-07-05 | 1978-06-15 | ||
| US4003991A (en) * | 1974-08-27 | 1977-01-18 | National Patent Development Corporation | Ophthalmic formulation |
| US4141973A (en) * | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
| US4136173A (en) * | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Mixed xanthan gum and locust beam gum therapeutic compositions |
| LU76955A1 (fr) * | 1977-03-15 | 1978-10-18 | ||
| US4271143A (en) * | 1978-01-25 | 1981-06-02 | Alcon Laboratories, Inc. | Sustained release ophthalmic drug dosage |
| US4255415A (en) * | 1978-11-22 | 1981-03-10 | Schering Corporation | Polyvinyl alcohol ophthalmic gel |
| US4272522A (en) * | 1979-10-15 | 1981-06-09 | Balazs Endre A | Method for stimulating phagocytic activity and synergistic compositions therefor |
| US4328803B1 (en) * | 1980-10-20 | 1994-01-11 | Opthalmic Systems, Inc. | Opthalmological procedures |
| US4675189A (en) * | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
| US4443432A (en) * | 1981-10-05 | 1984-04-17 | Alcon Laboratories, Inc. | Ophthmalic irrigating solution |
| JPS5945890A (ja) * | 1982-09-09 | 1984-03-14 | Toyo Jozo Co Ltd | 新規抗生物質アクミマイシンおよびその製造法 |
| US5002582A (en) * | 1982-09-29 | 1991-03-26 | Bio-Metric Systems, Inc. | Preparation of polymeric surfaces via covalently attaching polymers |
| US4452775A (en) * | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| US4517295A (en) * | 1983-02-18 | 1985-05-14 | Diagnostic, Inc. | Hyaluronic acid from bacterial culture |
| GB8318403D0 (en) * | 1983-07-07 | 1983-08-10 | Sutherland I W | Gel-forming polysaccharides |
| US4795436A (en) * | 1983-11-14 | 1989-01-03 | Bio-Mimetics, Inc. | Bioadhesive composition and method of treatment therewith |
| US4983392A (en) * | 1983-11-14 | 1991-01-08 | Bio-Mimetics, Inc. | Bioadhesive compositions and methods of treatment therewith |
| US5316926A (en) * | 1983-11-25 | 1994-05-31 | Miles Inc. | Method for the microbiological production of non-antigenic hyaluronic acid |
| US4500676A (en) * | 1983-12-15 | 1985-02-19 | Biomatrix, Inc. | Hyaluronate modified polymeric articles |
| US4911920A (en) * | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| US5409904A (en) * | 1984-11-13 | 1995-04-25 | Alcon Laboratories, Inc. | Hyaluronic acid compositions and methods |
| US5128326A (en) * | 1984-12-06 | 1992-07-07 | Biomatrix, Inc. | Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same |
| JPS61253065A (ja) * | 1985-05-02 | 1986-11-10 | 片倉チツカリン株式会社 | キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法 |
| US5202431A (en) * | 1985-07-08 | 1993-04-13 | Fidia, S.P.A. | Partial esters of hyaluronic acid |
| US4851521A (en) * | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| US5034514A (en) * | 1986-03-17 | 1991-07-23 | Cetus Corporation | Novel cross-linking agents |
| US4840626A (en) * | 1986-09-29 | 1989-06-20 | Johnson & Johnson Patient Care, Inc. | Heparin-containing adhesion prevention barrier and process |
| IL80298A (en) * | 1986-10-14 | 1993-01-31 | Res & Dev Co Ltd | Eye drops |
| EP0280155B1 (fr) * | 1987-02-25 | 1992-05-20 | Hoechst Aktiengesellschaft | Microencapsulation de substances biologiquement actives |
| US5108759A (en) * | 1987-04-01 | 1992-04-28 | Ranney David F | Endothelial envelopment drug carriers |
| US6387379B1 (en) * | 1987-04-10 | 2002-05-14 | University Of Florida | Biofunctional surface modified ocular implants, surgical instruments, medical devices, prostheses, contact lenses and the like |
| US5079236A (en) * | 1987-05-27 | 1992-01-07 | Hyal Pharmaceutical Corporation | Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use |
| IL83687A (en) * | 1987-08-30 | 1995-03-30 | Yeda Res & Dev | Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions |
| US5017229A (en) * | 1990-06-25 | 1991-05-21 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
| US6174999B1 (en) * | 1987-09-18 | 2001-01-16 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
| US5188826A (en) * | 1988-02-08 | 1993-02-23 | Insite Vision Incorporated | Topical ophthalmic suspensions |
| US5192535A (en) * | 1988-02-08 | 1993-03-09 | Insite Vision Incorporated | Ophthalmic suspensions |
| US5510329A (en) * | 1988-04-26 | 1996-04-23 | Ramot University For Applied Research And Industrial Development Ltd. | Preparations for the treatment of eyes |
| US4920104A (en) * | 1988-05-16 | 1990-04-24 | Medchem Products, Inc. | Sodium hyaluronate composition |
| US4908404A (en) * | 1988-08-22 | 1990-03-13 | Biopolymers, Inc. | Synthetic amino acid-and/or peptide-containing graft copolymers |
| CA2006060A1 (fr) * | 1988-12-20 | 1990-06-20 | Michael D. Pierschbacher | Conjugats polypeptide-polymere actifs dans la cicatrisation des plaies |
| US5783691A (en) * | 1989-02-08 | 1998-07-21 | Biomatrix, Inc. | Crosslinked hyaluronate gels, their use and method for producing them |
| US5132230A (en) * | 1989-03-28 | 1992-07-21 | Isolab, Inc. | Primary standard and method of making secondary standards for calibration of glycated protein assays |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| CA1340994C (fr) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Traitement de maladies et d'etats pathologiques |
| US5521222A (en) * | 1989-09-28 | 1996-05-28 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
| SE465950B (sv) * | 1989-10-23 | 1991-11-25 | Medinvent Sa | Kombination av ett aggregat partikelformat, kristallint eller frystorkat laekemedel med en pseudoplastisk gel foer beredning av ett injicerbart preparat samt foerfarande foer dess framstaellning |
| US5212162A (en) * | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| WO1994007505A1 (fr) * | 1991-07-03 | 1994-04-14 | Norpharmco Inc. | Utilisation de l'acide hyaluronique sous differentes formes contre la recidive de la stenose arterielle |
| EP0607339A4 (en) * | 1991-10-09 | 1994-08-10 | Hawaii Chemtect Int | Field kit for detecting analytes. |
| US5407686A (en) * | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US6235313B1 (en) * | 1992-04-24 | 2001-05-22 | Brown University Research Foundation | Bioadhesive microspheres and their use as drug delivery and imaging systems |
| US5645827A (en) * | 1992-09-30 | 1997-07-08 | Union Carbide Chemicals & Plastics Technology Corporation | Muco-adhesive polymers |
| WO1994018834A1 (fr) * | 1993-02-16 | 1994-09-01 | Virginia Tech Intellectual Properties, Inc. | Conjugaison polyelectrolyte-adn et transformation genetique d'un animal |
| EP0615745B1 (fr) * | 1993-02-19 | 1997-05-02 | Howard Green | Compositions contenant des protéines à partir de corneocytes |
| US6090925A (en) * | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
| US5643575A (en) * | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5650173A (en) * | 1993-11-19 | 1997-07-22 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of biodegradable microparticles containing a biologically active agent |
| US5773577A (en) * | 1994-03-03 | 1998-06-30 | Protein Polymer Technologies | Products comprising substrates capable of enzymatic cross-linking |
| ITPD940054A1 (it) * | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | Polisaccaridi solfatati |
| FR2719316B1 (fr) * | 1994-04-28 | 1996-05-31 | Idm | Nouveaux complexes d'acide nucléique et de polymère, leur procédé de préparation et leur utilisation pour la transfection de cellules. |
| SE9401806D0 (sv) * | 1994-05-26 | 1994-05-26 | Pharmacia Ab | Method and means for the production of hyaluronic acid |
| IT1273011B (it) * | 1994-07-25 | 1997-07-01 | Trhecnopharma S A | Preparato oftalmico per l'uso come lacrima artificiale |
| US5490980A (en) * | 1994-09-28 | 1996-02-13 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Covalent bonding of active agents to skin, hair or nails |
| US5620013A (en) * | 1994-10-21 | 1997-04-15 | American Cyanamid Company | Method for destroying residual lens epithelial cells |
| IT1274984B (it) * | 1994-12-09 | 1997-07-29 | Technopharma Sa | Soluzioni viscosizzate con ialuronato di sodio per l'uso come fluido maschera nella fotocheratectomia terapeutica mediante laser a accimeri |
| US5510102A (en) * | 1995-01-23 | 1996-04-23 | The Regents Of The University Of California | Plasma and polymer containing surgical hemostatic adhesives |
| US5817303A (en) * | 1995-05-05 | 1998-10-06 | Protein Polymer Technologies, Inc. | Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer |
| US6284284B1 (en) * | 1995-06-06 | 2001-09-04 | Advanced Tissue Sciences, Inc. | Compositions and methods for production and use of an injectable naturally secreted extracellular matrix |
| DE69632684T2 (de) * | 1995-06-27 | 2005-06-09 | Takeda Pharmaceutical Co. Ltd. | Verfahren zur herstellung von zubereitungen mit verzögerter freisetzung |
| US6265389B1 (en) * | 1995-08-31 | 2001-07-24 | Alkermes Controlled Therapeutics, Inc. | Microencapsulation and sustained release of oligonucleotides |
| EP0852501B1 (fr) * | 1995-09-28 | 2004-12-01 | Sangstat Medical Corporation | Utilisation d'acide hyaluronique en qualite d'agent immunosuppresseur |
| US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| ES2420106T3 (es) * | 1995-12-18 | 2013-08-22 | Angiodevice International Gmbh | Composiciones de polímeros reticulados y métodos para su uso |
| US6261584B1 (en) * | 1996-02-02 | 2001-07-17 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| ATE199908T1 (de) * | 1996-12-16 | 2001-04-15 | Nederlanden Staat | Verfahren zur kupplung von polysacchariden und proteinen |
| US5861149A (en) * | 1997-06-04 | 1999-01-19 | Polyheal Ltd. | Methods for wound treatment |
| US6229009B1 (en) * | 1997-08-29 | 2001-05-08 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Polycarboxylic based cross-linked copolymers |
| US6267957B1 (en) * | 1998-01-20 | 2001-07-31 | Howard Green | Attaching agents to tissue with transglutaminase and a transglutaminase substrate |
| US6958148B1 (en) * | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
| US6919076B1 (en) * | 1998-01-20 | 2005-07-19 | Pericor Science, Inc. | Conjugates of agents and transglutaminase substrate linking molecules |
| IL137128A0 (en) * | 1998-01-30 | 2001-07-24 | R Tech Ueno Ltd | Ophthalmic compositions containing tetrahydroquinazoline derivatives |
| US6200595B1 (en) * | 1998-04-24 | 2001-03-13 | Kuraray Co., Ltd. | Medical adhesive |
| US6378526B1 (en) * | 1998-08-03 | 2002-04-30 | Insite Vision, Incorporated | Methods of ophthalmic administration |
| US6335029B1 (en) * | 1998-08-28 | 2002-01-01 | Scimed Life Systems, Inc. | Polymeric coatings for controlled delivery of active agents |
| EP1117378A2 (fr) * | 1998-10-05 | 2001-07-25 | The Penn State Research Foundation | Compositions et procedes permettant d'augmenter l'internalisation cellulaire a mediation par les recepteurs |
| EP1140021B1 (fr) * | 1998-12-23 | 2004-08-04 | Idea Ag | Formulation amelioree pour l'application topique non invasive in vivo |
| AU3327000A (en) * | 1999-03-24 | 2000-10-09 | Seikagaku Corporation | Artificial saliva |
| JP2001081103A (ja) * | 1999-09-13 | 2001-03-27 | Denki Kagaku Kogyo Kk | ヒアルロン酸結合薬剤 |
| US6200599B1 (en) * | 1999-10-07 | 2001-03-13 | The Regents Of The University Of California | Ortho ester lipids |
| US6893462B2 (en) * | 2000-01-11 | 2005-05-17 | Regeneration Technologies, Inc. | Soft and calcified tissue implants |
| US6348508B1 (en) * | 2000-04-04 | 2002-02-19 | Bausch & Lomb Incorporated | Method for treating dry eye |
| WO2001086002A2 (fr) * | 2000-05-09 | 2001-11-15 | Genetics Institute, Llc | Compositions, kits, et procedes pour l'identification, l'evaluation, la prevention, et la therapie du psoriasis |
| IL140844A0 (en) * | 2001-01-10 | 2002-02-10 | Polygene Ltd | Cationic polysaccharide compositions |
-
2003
- 2003-07-03 MX MXPA05000186A patent/MXPA05000186A/es unknown
- 2003-07-03 NZ NZ537735A patent/NZ537735A/en not_active IP Right Cessation
- 2003-07-03 US US10/519,329 patent/US20060094643A1/en not_active Abandoned
- 2003-07-03 CN CN201310303034.3A patent/CN103638040A/zh active Pending
- 2003-07-03 WO PCT/US2003/021034 patent/WO2004004744A1/fr active Application Filing
- 2003-07-03 CN CN2011100712765A patent/CN102178692A/zh active Pending
- 2003-07-03 IL IL16591003A patent/IL165910A0/xx unknown
- 2003-07-03 AU AU2003256381A patent/AU2003256381A1/en not_active Abandoned
- 2003-07-03 BR BRPI0312331A patent/BRPI0312331A2/pt not_active IP Right Cessation
- 2003-07-03 EP EP03763195A patent/EP1539193A4/fr not_active Withdrawn
- 2003-07-03 CA CA002491054A patent/CA2491054A1/fr not_active Abandoned
- 2003-07-03 RU RU2005102604/15A patent/RU2005102604A/ru not_active Application Discontinuation
- 2003-07-03 CN CNA038177811A patent/CN1671400A/zh active Pending
- 2003-07-03 JP JP2004519871A patent/JP4818608B2/ja not_active Expired - Fee Related
-
2010
- 2010-07-05 JP JP2010153446A patent/JP2010270126A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RU2005102604A (ru) | 2005-09-10 |
| EP1539193A1 (fr) | 2005-06-15 |
| CN1671400A (zh) | 2005-09-21 |
| CA2491054A1 (fr) | 2004-01-15 |
| CN102178692A (zh) | 2011-09-14 |
| JP2006502988A (ja) | 2006-01-26 |
| NZ537735A (en) | 2006-08-31 |
| EP1539193A4 (fr) | 2010-05-05 |
| US20060094643A1 (en) | 2006-05-04 |
| JP4818608B2 (ja) | 2011-11-16 |
| BRPI0312331A2 (pt) | 2016-06-28 |
| JP2010270126A (ja) | 2010-12-02 |
| WO2004004744A1 (fr) | 2004-01-15 |
| CN103638040A (zh) | 2014-03-19 |
| MXPA05000186A (es) | 2005-08-17 |
| AU2003256381A1 (en) | 2004-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL165910A0 (en) | Compositions of hyaluronic acid and methods of use | |
| AU2003259735A8 (en) | Small-mer compositions and methods of use | |
| AU2003257937A8 (en) | Methods and compositions for treatment of dermal conditions | |
| HK1210032A1 (en) | Compositions and methods of delivery of pharmacological agents | |
| HK1079789A1 (zh) | 血管靜態毒性試劑及其使用方法 | |
| IL166608A0 (en) | Anti-microbial compositions and methods of using same | |
| EP1606285A4 (fr) | Inhibiteurs de ido et procedes d'utilisation de ceux-ci | |
| EP1562225A4 (fr) | Composition de nettoyage et procede pour nettoyer avec cette composition | |
| AU2003299441A8 (en) | Nf-hev compositions and methods of use | |
| EP1696910A4 (fr) | Compositions et procedes pour traiter une fibrose | |
| AU2003220361A8 (en) | Benzamides and compositions benzamides for use as fungizide | |
| IL205407A0 (en) | Hyaluronic acid antagonist and inhibitor compositions and uses thereof | |
| AU2003301240A8 (en) | Skin cleanser compositions and methods of use | |
| AU2003287443A8 (en) | Compositions and methods for pain reduction | |
| EP1476150A4 (fr) | Carboxyfullerenes et procedes d'utilisation de ceux-ci | |
| GB0208081D0 (en) | Skincare compositions and methods | |
| EP1663255A4 (fr) | Compositions de withanamide and withanolide et procede d'utilisation de celles-ci | |
| AU2003239868A8 (en) | Sunscreen compositions and methods of use thereof | |
| EP1625141A4 (fr) | Compositions a base de grp94 et procedes d'utilisation associes | |
| GB0324523D0 (en) | Compositions and methods of treatment | |
| EP1534293A4 (fr) | Compositions anti-inflammatoires et procedes d'utilisation | |
| AU2003215264A8 (en) | Compositions and methods for delivery of skin cosmeceuticals | |
| AU2003294684A8 (en) | Ketoprofen compositions and methods of making them | |
| AU2003282593A8 (en) | Polyphenolamine composition and method of use | |
| EP1414427A4 (fr) | Compositions a base de kavalactone et leurs procedes d'utilisation |